Point-of-Care Coagulation Testing Market by End-user and Geography - Forecast and Analysis 2021-2025

The point-of-care (POC) coagulation testing market share is expected to increase by USD 1.49 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.41%.

This point-of-care coagulation testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by end-user (hospitals and clinics and homecare) and geography (North America, Europe, Asia, and ROW). The point-of-care coagulation testing market report also offers information on several market vendors, including Abbott Laboratories, Danaher Corp., DIAGNOSTICA STAGO SAS, F. Hoffmann-La Roche Ltd., Helena Laboratories Corp., iLine Microsystems SL, Medtronic Plc, Micropoint Bioscience Inc., Siemens AG, and Sysmex Corp. among others.

What will the Point-of-Care Coagulation Testing Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Point-of-Care Coagulation Testing Market Size for the Forecast Period and Other Important Statistics

Point-of-Care Coagulation Testing Market: Key Drivers and Trends

The growing geriatric population is notably driving the POC coagulation testing market growth, although factors such as lack of trained professionals may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the point-of-care coagulation testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Point-of-Care Coagulation Testing Market Driver

The growing geriatric population will fuel the growth of the point-of-care coagulation testing market size during the forecast period. Aging increases the susceptibility to infections as the immune system deteriorates with age. Older adults require diagnostic testing on a regular basis due to their low immunity and slow metabolism. These factors have increased the demand for point-of-care blood coagulation analyzers as coagulation measurements can assist in diagnosing diseases. Physicians use the results of these blood tests to choose the most suitable line of treatment. Hence, an increasing older adult population indicates a growing demand for point-of-care coagulation testing, thus contributing to the growth of the market during the forecast period.

Key Point-of-Care Coagulation Testing Market Challenge

The inability to hire trained professionals would limit the use of point-of-care coagulation analyzers, which may hinder the growth of the market during the forecast period. There is a shortage of these specialists in diagnostic centers and hospitals globally. Generally, most rural hospitals in the US face issues such as the lack of patient volume required to justify having specialists. Most times, appointing in-house specialists is cost-prohibitive, especially for small medical facilities. Therefore, end-users such as hospitals and diagnostic centers need to invest significantly in providing training to their employees for laboratory testing and maintaining point-of-care coagulation analyzers.

This point-of-care coagulation testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Point-of-Care Coagulation Testing Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• Danaher Corp.
• DIAGNOSTICA STAGO SAS
• F. Hoffmann-La Roche Ltd.
• Helena Laboratories Corp.
• iLine Microsystems SL
• Medtronic Plc
• Micropoint Bioscience Inc.
• Siemens AG
• Sysmex Corp.

This statistical study of the point-of-care coagulation testing market encompasses successful business strategies deployed by the key vendors. The POC coagulation testing market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The point-of-care coagulation testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Point-of-Care Coagulation Testing Market?